Effect of socio-demographic factors on endogenous biomarkers (cystatin C and creatinine) among elderly chronic kidney disease patients: a cross-sectional study
- 65 Downloads
Creatinine is normally used to evaluate kidney function among elderly patients in clinical practice, which has been reported to be affected by socio-demographic factors like BMI and age. Cystatin C a newly introduced biomarker may be more efficient in identifying kidney function in obese and aged CKD patients. The aim of the current study was to assess the effect of BMI on endogenous biomarkers (cystatin C and creatinine) among elderly CKD patients in Malaysia, a first such study in the country.
The current study was conducted at the Hospital University Sains Malaysia, Kelantan. A total of 300 elderly Malay participants ≥ 65 years, with CKD, were taken in study. Demographic data, blood pressure, weight, and height were documented. Serum creatinine was assayed by Chemistry Analyzer Model Architect-C8000 (Jaffe Method), while serum cystatin C was examined by Human cystatin C ELISA kit (Sigma-Aldrich) using Thermo Scientific Varioskan Flash ELISA reader.
The study participants were divided into three groups on the basis of age. There was a statistically significant difference at the p value < 0.05 in serum creatinine level for the three age groups [F (2, 297) = 1.98, p value 0.045]. Patients were divided into four groups on the basis of BMI. The results of one-way ANOVA revealed a statistically significant difference at the p value < 0.05 in the mean serum creatinine level for the four groups [F (3, 396) = 2.99, p value 0.032]. However, no statistically significant differences between mean serum cystatin C levels were observed on the basis of patient’s age and BMI.
Cystatin C is not related to BMI and age among elderly chronic kidney disease patients. The study clearly evaluates the role of serum cystatin C as a good competitor of creatinine among the elderly CKD patients.
KeywordsCystatin C Creatinine Estimated GFR
All authors contributed in a professional way. IK collected the data and wrote the manuscript. AHK and ASA reviewed the manuscript. SASS and ABAH helped in English editing, while NA and AK shared their clinical expertise in the preparation of manuscript.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interests.
Human and animal rights statement
The study was approved by Human Resource Ethics Committee Jawatankuasa Etika Penyelidikan-Manusia (JEPeM) of HUSM (USM/JEPeM/1311553).
- 5.Sterner G, Frennby B, Mansson S, Nyman U, Van Westen D, Almén T (2008) Determining ‘true’ glomerular filtration rate in healthy adults using infusion of inulin and comparing it with values obtained using other clearance techniques or prediction equations. Scand J Urol Nephrol 42(3):278–285CrossRefPubMedGoogle Scholar
- 9.Grubb A (1991) Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 38:S20–S27Google Scholar
- 10.Rose B (2012) UpToDate—introduction to renal function. www.uptodate.com. Accessed 17 Oct 2017
- 13.Foundation NK (2002) Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification: National Kidney FoundationGoogle Scholar
- 27.Swedish Council on Health Technology Assessment (2013) Methods to estimate and measure renal function (Glomerular filtration rate)—a systematic review. ISBN: 978-91-85413-53-9, 2013. Report no. 214Google Scholar
- 30.Geigy scientific tables, 7th edn. Basle, Ciba-Geigy Ltd. 1971: 572,665. 1971Google Scholar
- 38.Śledziński T, Proczko-Markuszewska M, Kaska Ł, Stefaniak T, Świerczyński J (2012) Serum cystatin C in relation to fat mass loss after bariatric surgery. Polish J Surg 84(4):202–207Google Scholar
- 39.al HVe (2012) Validity of serum cystatin C for predicting obesity nephropathy. Interdiscip Bio Central 4(4):1–4Google Scholar
- 45.United States Renal data Systems. www.usrds.org. Accessed 17 Oct 2017
- 50.Begum R, Khan TM, Ming LC (2016) Burden of chronic kidney disease and its risk factors in Malaysia. J Epidemiol Glob Health. https://doi.org/10.1016/j.jegh.2016.03.004
- 51.National strategic plan for non-communicable disease (2010) Malaysia: Ministry of HealthGoogle Scholar